fda semaglutide shortage resolved 2025 announcement ๐จ Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Ozempic and Wegovy officially moved
Description
It was inevitable
As GLP-1 weight-loss drug costs surge, most Connecticut employers cover them but impose conditions like prior authorization and lifestyle requirements to manage expenses, a strategy the state employee plan has used to slow spending growth.
Insurance coverage for semaglutide weight loss remains limited despite rising demand
(Photo: Getty Images)
Key insights reveal potential vision risks associated with Wegovy and Ozempicwhat should you know before starting treatment?
Shima Hadidchi, in Apple Valley and Victorville, CA, Can Support Your Weight Loss Journey.
